Ayuda
Ir al contenido

Dialnet


Inhaled corticosteroids may have a protective effect against coronavirus infection

    1. [1] Hospital Universitario Pío del Río Hortega

      Hospital Universitario Pío del Río Hortega

      Valladolid, España

    2. [2] Pediatric Service, Delicias Center, Valladolid, Spain.
    3. [3] Medicina de Familia y Comunitaria, ASVAO, Valladolid, Spain.
    4. [4] Coordinadora de la Gerencia de Atención Primaria, Consejería de Sanidad, Madrid, Spain.
  • Localización: Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology, ISSN-e 1578-1267, ISSN 0301-0546, Vol. 49, Nº. 1, 2021, págs. 113-117
  • Idioma: inglés
  • Enlaces
  • Resumen
    • Background: Spain has been severely affected by the COVID-19 epidemic, with 195,944 persons infected and 20,453 deaths at the time of writing. Older people with respiratory or cardiac conditions are most at risk.

      Objective: The aim was to compare respiratory symptoms in nursing home residents and patients with uncontrolled asthma, who are considered vulnerable to COVID-19.

      Methods: We studied 134 nursing home residents and 139 patients with uncontrolled asthma, groups vulnerable to COVID-19. Demographic characteristics, clinical manifestations, outcomes, key laboratory results, and radiological images were collected from medical records. COVID-19 infection was detected by polymerase chain reaction (PCR).

      Results: Thirteen (9.3%) patients with uncontrolled asthma, all receiving inhaled corticosteroids were infected by COVID-19. Eighty (60%) nursing home residents were infected; only 28, all of whom had received inhaled corticosteroids, had a good prognosis.

      Conclusions: Early treatment with inhaled corticosteroids may be helpful in COVID-19 infection. Persons with an allergy might have some protective mechanisms against coronavirus.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno